FDA’s latest draft guidance emphasizes the agency’s desire for uniform definitions of “protocol deviations” and “important protocol deviations,” and adopts the definitions from ICH E3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback